The ongoing COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus 2 is a global public health crisis. Multiple observations indicate poorer post-infection outcomes for patients with cancer than for the general population. Herein, we highlight the challenges in caring for patients with acute leukaemias and myeloid neoplasms amid the COVID-19 pandemic. We summarise key changes related to service allocation, clinical and supportive care, clinical trial participation, and ethical considerations regarding the use of lifesaving measures for these patients. We recognise that these recommendations might be more applicable to high-income countries and might not be generalisable because of regional differences in health-care infrastructure, individual circumstances, and a complex and highly fluid health-care environment. Despite these limitations, we aim to provide a general framework for the care of patients with acute leukaemias and myeloid neoplasms during the COVID-19 pandemic on the basis of recommendations from international experts.

Special considerations in the management of adult patients with acute leukaemias and myeloid neoplasms in the COVID-19 era: recommendations from a panel of international experts / A.M. Zeidan, P.C. Boddu, M.M. Patnaik, J.P. Bewersdorf, M. Stahl, R.K. Rampal, R. Shallis, D.P. Steensma, M.R. Savona, M.A. Sekeres, G.J. Roboz, D.J. Deangelo, A.C. Schuh, E. Padron, J.F. Zeidner, R.B. Walter, F. Onida, A. Fathi, A. Dezern, G. Hobbs, E.M. Stein, P. Vyas, A.H. Wei, D.T. Bowen, P. Montesinos, E.A. Griffiths, A.K. Verma, A. Keyzner, M. Bar-Natan, S.C. Navada, M. Kremyanskaya, A.D. Goldberg, A. Al-Kali, M.L. Heaney, A. Nazha, H. Salman, S. Luger, K.W. Pratz, H. Konig, R. Komrokji, M. Deininger, B.X. Cirici, V.R. Bhatt, L.R. Silverman, H.P. Erba, P. Fenaux, U. Platzbecker, V. Santini, E.S. Wang, M.S. Tallman, R.M. Stone, J. Mascarenhas. - In: THE LANCET. HAEMATOLOGY. - ISSN 2352-3026. - 7:8(2020), pp. 601-612. [10.1016/s2352-3026(20)30205-2]

Special considerations in the management of adult patients with acute leukaemias and myeloid neoplasms in the COVID-19 era: recommendations from a panel of international experts

F. Onida;
2020

Abstract

The ongoing COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus 2 is a global public health crisis. Multiple observations indicate poorer post-infection outcomes for patients with cancer than for the general population. Herein, we highlight the challenges in caring for patients with acute leukaemias and myeloid neoplasms amid the COVID-19 pandemic. We summarise key changes related to service allocation, clinical and supportive care, clinical trial participation, and ethical considerations regarding the use of lifesaving measures for these patients. We recognise that these recommendations might be more applicable to high-income countries and might not be generalisable because of regional differences in health-care infrastructure, individual circumstances, and a complex and highly fluid health-care environment. Despite these limitations, we aim to provide a general framework for the care of patients with acute leukaemias and myeloid neoplasms during the COVID-19 pandemic on the basis of recommendations from international experts.
Settore MED/15 - Malattie del Sangue
Settore MED/17 - Malattie Infettive
2020
Article (author)
File in questo prodotto:
File Dimensione Formato  
main.pdf

accesso riservato

Descrizione: Viewpoint
Tipologia: Publisher's version/PDF
Dimensione 219.77 kB
Formato Adobe PDF
219.77 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/973968
Citazioni
  • ???jsp.display-item.citation.pmc??? 38
  • Scopus 52
  • ???jsp.display-item.citation.isi??? 47
social impact